Search
  • Capio Biosciences
    • Apr 11, 2019
    • 1 min read

Capio Biosciences to present at the Liquid Biopsy Summit in San Francisco June 17-19th 2019

Andrew Z. Wang, MD, CEO, Capio Biosciences will present "Capiocyte: A Highly Sensitive Circulating Tumor Cell Capture Assay for Improving Cancer Management"


Need more details? Contact us.

 

We are here to assist. If you require further information or are interested in collaborations or partnerships, contact us by phone, email or via our social media channels.

  • White LinkedIn Icon
  • White Twitter Icon
  • White Facebook Icon

505 S. Rosa Road
Suite 10C
Madison, WI 53719

info@capiobiosciences.com

​

​

* The CapioCyte System is currently under development and not for use in diagnostic procedures.

© COPYRIGHT 2017, 2018. ALL RIGHTS RESERVED. 

Capio and CapioCyte are trademarks of Capio Biosciences.